Lehrstuhl für Strahlentherapie

Address:
Universitätsstraße 27
91054 Erlangen



Subordinate Organisational Units

Professur für Med. Strahlenphysik
Professur für Strahlentherapie mit dem Schwerpunkt Brachytherapie


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 16 Go to next page Go to last page

Goerig, N., & Fietkau, R. (2019). Rolle der Radiotherapie beim Pankreaskarzinom. Onkologe, 25(8), 678-689. https://dx.doi.org/10.1007/s00761-019-0546-9
Koca, S., Distel, L., Lubgan, D., Weissmann, T., Lambrecht, U., Lang-Welzenbach, M.,... Putz, F. (2019). Time course of pain response and toxicity after whole-nerve-encompassing LINAC-based stereotactic radiosurgery for trigeminal neuralgia—a prospective observational study. Strahlentherapie und Onkologie, 195(8), 745-755. https://dx.doi.org/10.1007/s00066-019-01450-9
Hofheinz, R., Fokas, E., Allgaeuer, M., Polat, B., Klautke, G., Grabenbauer, G.,... Roedel, C. (2019). Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. In ANNALS OF ONCOLOGY. Barcelona, ES: OXFORD: OXFORD UNIV PRESS.
Weissmann, T., Semrau, S., Ott, O.J., Fietkau, R., & Putz, F. (2019). Radiation therapy in Graves'-opthalmopathy. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S48-S48). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Weissmann, T., Höfler, D., Semrau, S., Lettmaier, S., Fietkau, R., & Putz, F. (2019). Long-term Results of oligometastatic Head and Neck Tumors after local Treatment of all Metastases. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S131-S131). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Rueckert, M., Seitz, C., Deloch, L., Weiss, E.-M., Utz, S., Izydor, M.,... Frey, B. (2019). Hydrostatic High Pressure generated Whole Cell Tumor Vaccines in combination with Radiotherapy produce an immunogenic Tumor Microenvironment. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S156-S156). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Deloch, L., Fuchs, J., Rueckert, M., Fietkau, R., Frey, B., & Gaipl, U. (2019). Low-dose X-Rays influence the Macrophage Polarization interacting with Synovial Fibroblasts in an anti-inflammatory Manner. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S48-S48). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Hader, M., Rosin, A., Gekle, S., Wadepohl, M., Fietkau, R., Frey, B., & Gaipl, U. (2019). Ex vivo Hyperthermia of B16 Melanoma and MCF-7/MDA-MB-231 Breast Cancer Cells by Hot Water or Microwave Irradiation in a Circulatory Process. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S169-S169). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Becker, I., Donaubauer, A., Klein, G., Cheremina, O., Fournier, C., Cucu, A.,... Gaipl, U. (2019). Osteoimmunological Effects of Radon Therapy on Patients with chronic degenerative and/or inflammatory Diseases. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S47-S48). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Filimonova, I., Fietkau, R., & Putz, F. (2019). Anatomical Distribution and relative Frequency of Lymph Node Metastases in Prostate Cancer: Creation of a three-dimensional Model of High-risk Regions with potential Implications for the adjuvant Radiotherapy. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S154-S155). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Weissmann, T., Semrau, S., Lettmaier, S., Fietkau, R., & Putz, F. (2019). Investigation of Long Term Survival in Metastatic NSCLC with Driver Mutations under Molecular Targeted Therapy and Local Radiotherapy of all Tumor Manifestations. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S144-S144). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Putz, F., Oft, D., Lettmaier, S., Weissmann, T., & Fietkau, R. (2019). FSRT versus SRS for Patients with large Brain Metastases: A volume-based Analysis of local Control and Radionecrosis. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S35-S35). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Jost, T., Hecht, M., Fietkau, R., & Distel, L. (2019). Influence of the Kinase Inhibitor Palbociclib on the Migration of malignant and non-malignant Cells under Irradiation. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S171-S171). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Schenker, H., Schuster, B., Fietkau, R., & Distel, L. (2019). Scleroderma and Radiation Sensitivity. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S97-S97). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Abu-Hossin, N., Kallis, K., Strnad, V., Fietkau, R., & Bert, C. (2019). Quality Assurance in interstitial multi-catheter Brachytherapy using an electromagnetic Tracking System. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S186-S186). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Donaubauer, A., Gryc, T., Froehlich, B., Becker, I., Ott, O.J., Fietkau, R.,... Frey, B. (2019). The IMMO-LDRT01 Study: Immunomodulatory Effects of X-ray Irradiation in chronic degenerative and inflammatory Diseases. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S105-S105). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Echarti, A., Hecht, M., Fietkau, R., & Distel, L. (2019). Prognostic Importance of the CD8-based Immune Status Inflamed, immune-Excluded, and immune Desert in Head and Neck Cancer Patients can be further subdivided by regulatory T Cells. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S44-S44). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Hecht, M., Donaubauer, A., Becker, I., Rutzner, S., Lubgan, D., Lettmaier, S.,... Frey, B. (2019). Complete Remission with consecutive Pneumonitis in metastatic Bronchogenic Carcinoma after combination of Radiotherapy and Nivolumab - Immunological Correlate in peripheral Blood. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S158-S158). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Diefenhardt, M., Hofheinz, R.-D., Martin, D., Beissbarth, T., Arnold, D., Hartmann, A.,... Fokas, E. (2019). Leukocytosis and Neutrophilia as independent prognostic Biomarkers for clinical Outcome in the randomized Phase III CAO/ARO/AIO-04 Rectal Cancer Study. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S44-S45). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Lettmaier, S., Hecht, M., & Fietkau, R. (2019). First Erlang Experience with Durvalumab Maintenance Therapy after definitive Radiochemotherapy in Patients with NSCLC. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S73-S73). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.

Last updated on 2019-24-04 at 10:26